Myelitis  >>  Remicade (infliximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Remicade (infliximab) / J&J
HAM06, NCT00823641 / 2007-005554-23: The HAM Infliximab Study

Terminated
2
3
Europe
Infliximab
Imperial College London, Medical Research Council
HTLV-I-associated Myelopathy
03/11
03/11

Download Options